'Mini liver tumors' created in a dish for the first timeNovember 13, 2017
Scientists have created mini biological models of human primary liver cancers, known as organoids, in the lab for the first time. In a paper published today in Nature Medicine, the tiny laboratory models of tumours were used to identify a new drug that could potentially treat certain types of liver cancer.
Primary liver cancer is the second most lethal cancer worldwide. To better understand the biology of the disease and develop potential treatments, researchers need models that can grow in the lab and accurately reflect how the tumours behave in patients. Previously, cultures of cells had been used but these are hard to maintain and fail to recreate the 3D structure and tissue architecture of human tumours.
The researchers created the mini tumours (up to 0.5mm) - termed tumouroids - to mimic the three most common forms of primary liver cancer. The tumour cells were surgically removed from eight patients and grown in a solution containing specific nutrients and substances which prevent healthy cells out-competing the tumour cells. The team, from the Wellcome/Cancer Research UK Gurdon Institute in Cambridge, used the tumouroids to test the efficacy of 29 different drugs, including those currently used in treatment and drugs in development. One compound, a type of protein inhibitor, was found to inhibit the activation of a protein called ERK in two of the three types of tumouroids, a crucial step in the development of liver cancer.
The researchers then tested this compound in vivo, transplanting two types of tumouroids into mice and treating them with the drug. A marked reduction in tumour growth was seen in mice treated with the drug, identifying a potential novel treatment for some types of primary liver cancer.
The tumouroids were able to preserve tissue structure as well as the gene expression patterns of the original human tumours from which they were derived. The individual subtypes of three different types of liver cancer, as well as the different tumour tissues which they came from, were all still distinguishable even after they had been grown in a dish for a long time. As the tumouroids retain the biological features of their parent tumour, they could play an important role in developing personalised medicine for patients.
The creation of biologically accurate models of tumours will also reduce the number of animals needed in certain experiments. Animal studies will still be required to validate findings, but the tumouroids will allow scientists to explore key questions about the biology of liver cancer in cultures rather than mice.
Lead researcher Dr Meritxell Huch, a Wellcome Sir Henry Dale Fellow from the Gurdon Institute, said: "We had previously created organoids from healthy liver tissue, but the creation of liver tumouroids is a big step forward for cancer research. They will allow us to understand much more about the biology of liver cancer and, with further work, could be used to test drugs for individual patients to create personalised treatment plans."
Dr Andrew Chisholm, Head of Cellular and Developmental Sciences at Wellcome said: "This work shows the power of organoid cultures to model human cancers. It is impressive to see just how well the organoids are able to mimic the biology of different liver tumour types, giving researchers a new way of investigating this disease. These models are vital for the next generation of cancer research, and should allow scientists to minimise the numbers of animals used in research."
Dr Vicky Robinson, Chief Executive of the NC3Rs which partially funded the work, said: "We are pleased to see that the funds from our annual 3Rs prize, sponsored by GlaxoSmithKline, have furthered Dr Huch's research. Each year the prize recognises exceptional science which furthers the 3Rs, and the work being conducted by Meri and her team is continuing to make progress in this area. This new breakthrough involving liver cancer organoids has the potential to reduce the number of animals required in the early stages of liver cancer research, and provide more biologically accurate models of human tumours."
Notes to editors
Emily Pritchard, Wellcome
The paper Human primary liver cancer-derived organoid cultures for disease modelling and drug screening is published in Nature Medicine http://dx.doi.org/10.1038/nm.4438 (URL will go live after embargo lifts)
About the Wellcome/Cancer Research UK Gurdon Institute
Named after its co-founder, Nobel Laureate Sir John Gurdon, the Gurdon Institute is a world-leading centre for research into the fundamental processes of biology and development, and how these go wrong in diseases such as cancer. More than 240 scientists work in the Institute's purpose-built laboratories on projects ranging from breast cancer and brain development to liver regeneration and leukaemia. Many have made pioneering contributions to the fields of basic cell biology, cellular reprogramming, epigenetics and DNA repair. Institute scientists use a range of model systems such as yeast, nematode worms, fruit flies, frogs, mammalian cells and organoids to study development and disease at the level of molecules, cells and tissues. Research conducted at the Institute has so far led to 11 spin-out companies (including Abcam, CellCentric, MISSION Therapeutics and Gen2 Neuroscience) and several candidate therapeutics have entered clinical trials. One of these, olaparib (Lynparza), has been approved in the UK, Europe and the USA for use against ovarian cancers. http://www.gurdon.cam.ac.uk
About the NC3Rs
The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) is a leading independent scientific organisation dedicated to replacing, refining and reducing the use of animals in research and testing (the 3Rs). It supports the UK science base by driving and funding innovation and technological developments that minimise the need for animals in research and testing, and lead to improvements in welfare where animals continue to be used. It funds research, supports training and development, and stimulates changes in regulations and practice. Primarily funded by Government, the NC3Rs is also supported by the charitable and private sectors. It works with scientists in universities and industry in the UK and internationally. http://www.nc3rs.org.uk
About Cancer Research UK Cambridge Centre
The Cancer Research UK Cambridge Centre is a dynamic collaboration of over 600 academic researchers, clinicians, and scientists in the pharmaceutical and biotech industries, based in the Cambridge area. The Centre combines world-class science and technology with excellent patient care to pioneer new ways to prevent, detect, diagnose and treat cancer. By working together across different disciplines, the Centre is breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science faster. The formal partners of the Cancer Research UK Cambridge Centre are Cancer Research UK, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. http://www.crukcambridgecentre.org.uk
Wellcome exists to improve health for everyone by helping great ideas to thrive. We're a global charitable foundation, both politically and financially independent. We support scientists and researchers, take on big problems, fuel imaginations and spark debate. Wellcome.ac.uk
Related Liver Cancer Articles:
A new report provides an overview of incidence, mortality, and survival rates and trends for liver cancer, a cancer for which death rates have doubled in the United States since the mid-1980s
Recent research results from the European consortium IT-Liver provide a better understanding of the role of the TGF-beta cytokine in liver cancer.
Hepatocellular carcinoma (HCC) is a deadly disease with no effective cure that develops in the context of liver diseases associated with chronic inflammation.
Manuela Baccarini and her team at the Max F. Perutz Laboratories (MFPL) of the University of Vienna and Medical University of Vienna are one step closer to unraveling the mechanisms behind liver cancer.
There's new hope for patients with liver disease who are waiting for a donor liver to become available for transplantation.
A UCF College of Medicine researcher has identified for the first time a tiny liver protein that when disrupted can lead to the nation's top killer -- cardiovascular disease -- as well as fatty liver disease, a precursor to cancer.
Researchers at the University of Eastern Finland and Eberhard Karls Universität Tübingen have discovered a new molecular mechanism that can be used to inhibit the growth of hepatocellular carcinoma, which is the most common liver cancer.
Because liver failure often occurs after an extensive hepatectomy, researchers using animal models investigated safer ways to transplant liver cells post-extensive hepatectomy found that rather than transplanting cells into the liver portal vein, transplantation into an extra-hepatic site, such as the intra-mesentery, a fold of membranous tissue on the posterior wall of the abdominal cavity attached to the intestinal tract, can help protect against post-operative liver failure and aid in survival of the remaining liver.
Researchers have found the 'bad seeds' of liver cancer and believe they could one day reprogram them to remain responsive to cancer treatment, a new USC study has found.
Researchers have found that retroviral long-terminal-repeat (LTR) promoters -- a type of repetitive element that are widely distributed in the human genome -- are highly activated in hepatocellular carcinomas, the most common type of liver cancer.
Related Liver Cancer Reading:
100 Questions & Answers About Liver Cancer
by Ghassan K. Abou-Alfa (Author), Ronald DeMatteo (Author)
Now in it's Third Edition, Dx/Rx: Liver Cancer is a quick and practical reference guide containing all aspects of the diagnosis and therapy of hepatocellular carcinoma (HCC), prognostic and staging systems, clinical management, molecular biology, current controversies, and future insights. Organized into a condensed, bulleted format, this concise reference offers precise and up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors for cancers of the liver.
Presented in a handy, easy-to-read format, Dx/Rx: Liver Cancer is a must-have resource... View Details
Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)
by Chen Liu (Editor)
This volume provides the most updated knowledge on the advancement of molecular pathogenesis, molecular diagnosis, and therapy development for hepatocellular carcinoma (HCC). Topics covered include the etiology and pathogenesis of HCC, recent advances in HCC genomics, biomarker discovery and validation in HCC diagnosis, the role of liver biopsy in HCC early diagnosis, and the future prospects of surgical approaches and targeted therapy for HCC. In addition to reviewing the current available knowledge, the book also discusses the future development of a precision and personalized medicine... View Details
Healing Colon, Liver & Pancreatic Cancer - The Gerson Way
by Charlotte Gerson (Author)
This booklet introduces Dr. Max Gerson and reviews the founding principle of the Gerson Therapy, that cancer and most chronic diseases are able to manifest in the body because of toxicity and nutritional deficiency. Charlotte Gerson gives an overview of the Gerson Therapy and reviews some of the methods used in the program. Also included are case histories of Individuals confronted with colon, liver and pancreatic cancer and how they overcame them using Gerson Therapy.View Details
Liver Cancer Causes, Symptoms, Stages & Treatment Guide: Cure Liver Cancer With A Positive Outlook
This book contains proven steps and strategies on how to cure liver cancer with a positive outlook.
This book is basically an information guide that will help you gain a deeper understanding about liver cancer – its basic definition, its causes, signs, symptoms, treatment and ways of coping.
This book also provide a guide about how you can cope with it with a positive outlook, support and knowledge.
Chapter 1- The Liver and its Functions
Chapter 2- Liver Cancer: Signs & Symptoms
Chapter 3- The Causes of Liver Cancer
Chapter 4- Liver Cancer:... View Details
Alpha Lipoic Acid Breakthrough: The Superb Antioxidant That May Slow Aging, Repair Liver Damage, and Reduce the Risk of Cancer, Heart Disease, and Diabetes
by Burt Berkson (Author)
The Amazing Antioxidant Everyone Is Talking About!
Are you looking for an effective way to fight the effects of aging and free radical damage? Would you like to reach and maintain your body's optimal health? There may be no stronger way than with antioxidants—and there may be no stronger antioxidant than alpha lipoic acid. This remarkable coenzyme, which occurs naturally in younger bodies but gradually diminishes with age, may very well be one of our best defenses against disease and aging. In this balanced and informative book, Burt Berkson, M.D., shows you how... View Details
Prayer | The 100 Most Powerful Prayers for Cancer | 2 Amazing Bonus Books to Pray for Miracles & Daily Prayers: Establish Inner Dialogue to Make Every Day Amazing (Volume 38)
by Toby Peterson (Author)
Audio Version is Now Available with Audible! Exclusive Offer — Today Includes 2 Amazing Bonus Books: The 100 Most Powerful Prayers for a Miracle & The 100 Most Powerful Daily Prayers
You will not achieve fulfillment and happiness until you allow God to be the architect of your reality. Imagine that with a few moments each day, you could begin the powerful transformation toward complete control of your own life and well being through prayer.
You will be able to release all fear and doubt simply because you know that God gives you the strength. You... View Details
Find out what else can be done for liver cancer when nothing else worked. View Details
Liver Cancer: Your Way Forward
by Abaco Publishing
You will never cure anything if you don’t do something about the underlying cause. This applies to every illness including liver cancer. In my book ‘Liver Cancer – Your way forward’ I explain why it may have developed, giving you something to do to change the underlying causes and bring things under control. As your liver takes most of the blood from your intestines, it is likely that you have eaten or drunk something that it couldn’t handle properly, combined with general bad eating habits, a poor immune system, infections, too many antibiotics, toxic chemicals, geopathic stress... View Details
Liver Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Liver Cancer - Revised Edition - Illustrated by S. Smith
by Department of Health and Human Services (Author), National Institutes of Health (Author), S. Smith (Editor), S. Smith (Editor)
This Liver Cancer Book is the revised version of the popular original version titled " Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Liver Cancer ", written by the: U.S. Department of Health and Human Services (Author), National Institute of Mental Health (Author), (Author), National Institutes of Health (Author) and S.Smith (Editor) and (Illustrator) This book has been professionally illustrated and edited with a fully hyper-linked table of contents for ease of navigation. A detailed booklet that describes Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Liver Cancer,... View Details